Combined use of two monoclonal antibodies in patients with systemic AL amyloidosis and cardiac involvement.

8009Background: Systemic AL amyloidosis (AL) is a rare disease in which circulating immunoglobulin light chains misfold, are directly toxic to key organs and also cause organ failure by mass effect...